SCHEMBL4392864

SCHEMBL4392864

CCc1c(C(=O)O)cccc1C1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 4/20 0.44
KMO O15229 1/20 0.42
ACMSD Q8TDX5 2/20 0.41
ALDH1A1 P00352 4/20 0.40
CYP1A2 P05177 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ABCC1 P33527 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NOTUM Q6P988 1/20 0.38
CLCN2 P51788 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1514834 0.92 NOTUM (0.43) PTGDR2ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL5599182 0.87 KDM4E (0.44) PTGDR2KDM4EHTTKMT2A
SCHEMBL5001042 0.87 NOTUM (0.40) PTGDR2ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL5001048 0.87 NOTUM (0.40) PTGDR2ALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL5520149 0.84 ACMSD (0.40) PTGDR2KMOACMSD
SCHEMBL8447500 0.82 CYP2C9 (0.43) ALDH1A1CYP1A2HPGDHSD17B10KMT2A
SCHEMBL3096090 0.81 PTGDR2 (0.40) PTGDR2KMOACMSDALDH1A1CYP1A2
SCHEMBL30281099 0.79 DRD2 (0.45) ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL11205492 0.79 PTGDR2 (0.40) PTGDR2KDM4EKMT2ATDP1
SCHEMBL9403931 0.79 ACMSD (0.50) PTGDR2KMOACMSDALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091949-A1 INDOLE DERIVATIVES AS S1P1 RECEPTOR AGONISTS Glaxo Group Limited (GB) 2009-08-26 EP disclosed
WO-2008074821-A1 INDOLE DERIVATIVES AS S1P1 RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2008-06-26 WO disclosed